Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Kawasaki's disease
ADR ID BADD_A02439
ADR Hierarchy
10      Immune system disorders
10.02      Immune disorders NEC
10.02.02      Vasculitides
10.02.02.009      Kawasaki's disease
11      Infections and infestations
11.07      Ancillary infectious topics
11.07.01      Inflammatory disorders following infection
11.07.01.007      Kawasaki's disease
24      Vascular disorders
24.12      Vascular infections and inflammations
24.12.02      Arterial infections and inflammations
24.12.02.004      Kawasaki's disease
Description An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities. [MeSH]
MedDRA Code 10023320
MeSH ID D009080
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Acute febrile mucocutaneous lymph node syndrome (MCLS) | Kawasaki's disease | Mucocutaneous lymph node syndrome | Mucocutaneous Lymph Node Syndrome | Kawasaki Syndrome | Lymph Node Syndrome, Mucocutaneous | Kawasaki Disease
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00039Acyclovir--
BADD_D00129Amoxicillin0.000012%
BADD_D00405Ceftriaxone0.004457%
BADD_D00551Cyclosporine0.000111%
BADD_D00932Fluoxetine0.000020%
BADD_D01243Lamotrigine0.000055%
BADD_D01867Propranolol0.000053%
BADD_D02093Sulfasalazine--
BADD_D02105Tacrolimus0.000297%
The 1th Page    1    Total 1 Pages